China
Africa
Explore chapters and articles related to this topic
Chronic Headache Pain
Published in Andrea Kohn Maikovich-Fong, Handbook of Psychosocial Interventions for Chronic Pain, 2019
RuthAnn R. Lester, Eleanor S. Brammer, Allison Gray
New daily persistent headache (NDPH) is another primary headache disorder that negatively impacts quality of life for patients and is particularly challenging for providers to manage (Robbins et al., 2010). The one-year population prevalence of NDPH has been reported at 0.03– 0.1%, and NDPH affects children more than adolescents and adolescents more than adults. Youth are more likely to experience NDPH than chronic tension-type headaches. NDPHs develop very quickly and are unrelenting. NDPH often is refractory to many medications and commonly becomes chronic (Tyagi, 2012). Headache pain can last for years, regardless of the best treatment options, but often stops as suddenly as it starts; most patients experience complete remission in two years (Robbins et al., 2010).
Tension-Type Headache
Published in Gary W. Jay, Clinician’s Guide to Chronic Headache and Facial Pain, 2016
By definition, primary chronic daily headache (CDH) is a headache disorder with headaches occurring 15 days or more of the month, lasting four or more hours per day, and with no secondary cause (46). Approximately 4% to 5% of the general population suffers with CDH (47,48). It can manifest as CTTH, transformed migraine, hemicrania continua, or new daily persistent headache.
Symptoms of Neurological Disease
Published in John W. Scadding, Nicholas A. Losseff, Clinical Neurology, 2011
Tim Fowler, Nick Losseff, John Scadding
A group of patients describe the sudden onset of headache on a specific day which then persists: this may be ‘new daily persistent headache’. Some of these are secondary to a defined cause, e.g. head trauma, raised intracranial pressure, meningitis. The headache of spontaneous low intracranial pressure may also have a specific onset time.
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant
Published in Expert Review of Neurotherapeutics, 2023
César Fernández-de-Las-Peñas, Maria L Cuadrado, Victor Gómez-Mayordomo, David García-Azorín, Lars Arendt-Nielsen
Figure 1 shows a possible classification of post-COVID headache according to the presence or absence of a history of primary headache and the presence or absence of headache as a symptom in the acute phase. There are two interconnected classifications. First, if a patient has a previous history of headache, clinicians must differentiate whether the post-COVID headache is a ‘new’ condition or an ‘exacerbated’ symptom. The International Classification of Headache Disorders clarifies that if a patient with a previous primary headache disorder experiences at least a twofold worsening in terms of headache frequency or intensity, both the primary headache disorder and the secondary headache disorder should be diagnosed, with the most disabling headache for the patient listed first [31]. Secondly, the onset of headache in the acute phase of infection could lead to post-COVID persistent headache with new daily persistent headache (NDPH) features. Indeed, patients who experience headache in the acute phase have a clear point of onset of headache and may continue with persistent headache from that day onwards. In individuals who do not present headache as a symptom of onset, post-COVID headache may occasionally begin after the acute phase, usually within the first two months after infection. This ‘late onset’ post-COVID headache may adopt a migraine or tension-type headache phenotype [10–12].
A systematic review of the efficacy of ketamine for craniofacial pain
Published in Canadian Journal of Pain, 2023
Yasmine Hoydonckx, Tyler McKechnie, Miki Peer, Marina Englesakis, Pranab Kumar
We found 12 observational studies including 317 patients (50% females) with the following diagnoses: chronic migraine (CM; n = 222), cluster headache (CH)–episodic (n = 17) or chronic (CCH; n = 57), short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT; n = 4), medication overuse headache (MOH; n = 37), and new daily persistent headache (NDPH; n = 17).29–40 Baseline pain intensity was moderate to severe in all observational studies. The duration of headache history was only provided in 3 studies.23,30,37
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes
Published in Expert Review of Neurotherapeutics, 2022
Nikolaos Giagkou, Ioanna Spanou, Dimos D. Mitsikostas
On the other hand, because the postural component of the headache might be lost overtime, but patients often remember the exact time that the headache began, SIH must also be differentiated from new daily persistent headache [39]. Finally, SIH should be differentiated from the causes of thunderclap headache, in the uncommon instances when SIH presents with this syndrome [39]. Patients have been reported in the literature to be misdiagnosed as having meningitis, migraine, tension-type headache, subarachnoid hemorrhage, and Chiari malformation [61,94].